AI for Drug Repurposing- An Interview with Ian Roberts, Healx Front Line Genomics

The Digital DNA series explores the role of large-scale genetic testing in science, industry and society. We aim to understand both the benefits and risks of this emerging technology and see what the future may hold. In the finale of our Digital DNA series we talked to Dr Ian Roberts, the Chief Technology Officer of Healx. He describes how Healx uses artificial intelligence (AI) to repurpose already-approved drugs as treatments for rare diseases. IR: Healx are an AI-powered biotech, and we accelerate the discovery and development of treatments for rare diseases.